Picture of Centrica logo

CNA — Centrica News Story

0.000.00%
gb flag iconLast trade - 00:00
UtilitiesBalancedLarge CapContrarian

Director/PDMR Shareholding

RNS Number : 7691X

Centrica PLC

23 March 2026

 

Centrica plc (the "Company")

23 March 2026

Notification of Transactions of Directors

The Company announces that it was notified on 23 March 2026 of the following transactions in respect of the Company's Ordinary Shares of 614/81 pence ("Shares") relating to Executive Directors.

The following notification, made pursuant to Article 19 of the Market Abuse Regulation, provides further details.   

Release following holding period of Annual Incentive Plan Deferred Shares

On 23 March 2026, Shares were released to an Executive Director following the end of the three-year holding period.  The shares were awarded on 21 March 2023 as a result of the Annual Incentive Plan award relating to the 2022 financial year.

All Shares, following the sale of Shares to cover statutory withholding liabilities, will be held until the minimum shareholding requirement is reached.

1Details of the person discharging managerial responsibilities/person closely associated
a)Name(s)Chris O'Shea
2Reason for the notification
a)Position/statusExecutive Director
b)Initial notification/AmendmentInitial Notification
3Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)NameCentrica plc
b)LEIE26EDV109X6EEPBKVH76
4Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial
instrument, type of instrument
Identification code
Ordinary Shares of 6 14/81pence
GB00B033F229
b)Nature of the transactionOrdinary Shares acquired following the end of the three-year holding period. The Shares were originally awarded on21 March 2023as a deferred award under the Annual Incentive Plan
c)Price(s) and volume(s)
PriceVolume
Nil694,925
d)Aggregated information
- Aggregated volume
- Price
694,925
nil
e)Date of the transaction23 March 2026
f)Place of the transactionOutside a trading venue
4Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial
instrument, type of instrument
Identification code
Ordinary Shares of 6 14/81pence
GB00B033F229
b)Nature of the transactionSale of Shares to cover statutory withholding liabilities due on the vesting of deferred Annual Incentive Plan Shares.
c)Price(s) and volume(s)
Number of Shares sold to cover statutory withholding liabilitiesPrice
327,270199.6251p
d)Aggregated information
- Aggregated volume
- Price
327,270
199.6251p
e)Date of the transaction23 March 2026
f)Place of the transactionLondon Stock Exchange (XLON)
    Vesting of the Restricted Share Plan award under the Long-Term Incentive Plan Restricted Share Plan (RSP) awards granted under Centrica plc's Long Term Incentive Plan on 21 March 2023 vested on 23 March 2026. As reported in the Company's 2025 Annual Report and Accounts, the vesting of the RSP award was subject to a performance underpin assessed over the three-year period from 1 January 2023 to 31 December 2025.  The Committee concluded that the RSP award would vest in full. Following the sale of Shares to cover statutory withholding liabilities, the remaining Shares will be held for a mandatory two-year holding period.  
1Details of the person discharging managerial responsibilities/person closely associated
a)Name(s)Chris O'Shea
2Reason for the notification
a)Position/statusExecutive Director
b)Initial notification/AmendmentInitial Notification
3Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)NameCentrica plc
b)LEIE26EDV109X6EEPBKVH76
4Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial
instrument, type of instrument
Identification code
Ordinary Shares of 6 14/81pence
GB00B033F229
b)Nature of the transactionVesting on 23 March 2026 of nil cost conditional award granted on 21 March 2023 under the LTIP and subsequent sale of Shares to cover statutory withholding liabilities. The remaining Shares are subject to a mandatory two-year holding period.
c)Price(s) and volume(s)
PriceVolume
Nil1,294,028
d)Aggregated information
- Aggregated volume
- Price
1,294,028
nil
e)Date of the transaction23 March 2026
f)Place of the transactionOutside a trading venue
4Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial
instrument, type of instrument
Identification code
Ordinary Shares of 6 14/81pence
GB00B033F229
b)Nature of the transactionSale of Shares to cover statutory withholding liabilities due on the vesting of LTIP.
c)Price(s) and volume(s)
Number of Shares sold to cover statutory withholding liabilitiesPrice
609,412199.6251p
d)Aggregated information
- Aggregated volume
- Price
609,412
199.6251p
e)Date of the transaction23 March 2026
f)Place of the transactionLondon Stock Exchange (XLON)
       
1Details of the person discharging managerial responsibilities/person closely associated
a)Name(s)Russell O'Brien
2Reason for the notification
a)Position/statusExecutive Director
b)Initial notification/AmendmentInitial Notification
3Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)NameCentrica plc
b)LEIE26EDV109X6EEPBKVH76
4Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial
instrument, type of instrument
Identification code
Ordinary Shares of 6 14/81pence
GB00B033F229
b)Nature of the transactionVesting on 23 March 2026 of nil cost conditional award granted on 21 March 2023 under the LTIP and subsequent sale of Shares to cover statutory withholding liabilities. The remaining Shares are subject to a mandatory two-year holding period.
c)Price(s) and volume(s)
PriceVolume
Nil714,493
14,493d)Aggregated information
- Aggregated volume
- Price
714,493
nil
e)Date of the transaction23 March 2026
f)Place of the transactionOutside a trading venue
4Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial
instrument, type of instrument
Identification code
Ordinary Shares of 6 14/81pence
GB00B033F229
b)Nature of the transactionSale of Shares to cover statutory withholding liabilities due on the vesting of LTIP .
c)Price(s) and volume(s)
Number of Shares sold to cover statutory withholding liabilitiesPrice
336,485199.6251p
d)Aggregated information
- Aggregated volume
- Price
336,485
199.6251p
e)Date of the transaction23 March 2026
f)Place of the transactionLondon Stock Exchange (XLON)
        Centrica plc is listed on the London Stock Exchange (CNA) Registered Office: Millstream, Maidenhead Road, Windsor, Berkshire SL4 5GD Registered in England & Wales number: 3033654 Legal Entity Identifier number: E26EDV109X6EEPBKVH76 ISIN number: GB00B033F229 This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com. RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.   END     DSHPPURAWUPQGMW

Recent news on Centrica

See all news